Wellington Management Group
RLAY icon

Wellington Management Group’s Relay Therapeutics RLAY Stock Holding History

Wellington Management Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$592K Buy
+59,508
New +$532K ﹤0.01% 1757
2024
Q3 		– Sell
-71,913
Closed -$469K – 2011
2024
Q2 		$469K Buy
71,913
+18,499
+35% +$126K ﹤0.01% 1785
2024
Q1 		$443K Sell
53,414
-47,747
-47% -$466K ﹤0.01% 1822
2023
Q4 		$1.11M Buy
101,161
+12,059
+14% +$102K ﹤0.01% 1608
2023
Q3 		$749K Buy
89,102
+1,369
+2% +$14.7K ﹤0.01% 1646
2023
Q2 		$1.1M Sell
87,733
-762,767
-90% -$9.49M ﹤0.01% 1592
2023
Q1 		$14M Sell
850,500
-200,925
-19% -$3.6M ﹤0.01% 1016
2022
Q4 		$15.7M Buy
1,051,425
+393,040
+60% +$7.52M ﹤0.01% 976
2022
Q3 		$14.7M Sell
658,385
-1,388,967
-68% -$30.5M ﹤0.01% 998
2022
Q2 		$34.3M Buy
2,047,352
+26,838
+1% +$575K 0.01% 787
2022
Q1 		$60.5M Buy
2,020,514
+21,966
+1% +$533K 0.01% 699
2021
Q4 		$61.4M Buy
1,998,548
+590,707
+42% +$18.7M 0.01% 773
2021
Q3 		$44.4M Buy
1,407,841
+139,654
+11% +$4.7M 0.01% 849
2021
Q2 		$46.4M Buy
1,268,187
+423,083
+50% +$13.9M 0.01% 845
2021
Q1 		$29.2M Buy
845,104
+701,573
+489% +$30.4M 0.01% 968
2020
Q4 		$5.97M Sell
143,531
-77,257
-35% -$3.49M ﹤0.01% 1289
2020
Q3 		$9.4M Buy
+220,788
New +$8.42M ﹤0.01% 1120

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Wellington Management Group's RLAY Position: Q1 2026 in Review

Wellington Management Group opened a new position in Relay Therapeutics (RLAY) in Q1 2026: 59,508 shares worth $592K. The stake represents ﹤0.01% of the portfolio and ranks #1757 among its holdings. This is a return to the name: Wellington Management Group previously reported a position in RLAY as recently as Q2 2024.

Wellington Management Group first reported a position in RLAY in Q3 2020 and has held it in 17 quarters since. The position peaked at $61.4M in Q4 2021. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Wellington Management Group held 59,508 shares of Relay Therapeutics worth $592K as of Q1 2026.
  • Relay Therapeutics was a new Wellington Management Group position in Q1 2026.
  • Relay Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1757 holding.
  • Wellington Management Group first reported a position in Relay Therapeutics in Q3 2020 and has held it in 17 quarters since.
  • Wellington Management Group's Relay Therapeutics position peaked at $61.4M in Q4 2021.
  • 242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.